{"123251":{"#nid":"123251","#data":{"type":"event","title":"BBUGS Public Policy Seminar","body":[{"value":"\u003Cp\u003E\u003Cstrong\u003EFACT\u003C\/strong\u003E: Haemophilus influenzae type b (Hib) is a bacterial disease that causes pneumonia and meningitis, particularly in young children. It is responsible for 3,000,000 illnesses and 400,000 deaths every year.\u003C\/p\u003E\u003Cp\u003E\u003Cstrong\u003EFACT\u003C\/strong\u003E: A safe and effective vaccine for Hib has existed for over 20 years. Which means that, theoretically, the lives of up to 8 million now dead kids could have been saved, had the vaccine immediately gone into widespread use.\u003C\/p\u003E\u003Cp\u003E\u003Cstrong\u003EFACT\u003C\/strong\u003E: The vaccine didn\u0027t go into widespread use. But then it did.\u003C\/p\u003E\u003Cp\u003E\u0026nbsp;Want to know what changed? \u003Cstrong\u003EThe Hib Initiative implemented a strategy that involved research, communications and intense coordination to accelerate vaccine uptake. \u003C\/strong\u003E\u003C\/p\u003E\u003Cp\u003E\u0026nbsp;If you want to hear a really interesting story don\u0027t miss this seminar \u2026 Hope to see you and \u003Cstrong\u003Esnacks will be provided\u003C\/strong\u003E!\u003C\/p\u003E\u003Cp\u003E\u003Cstrong\u003ESpeaker\u003C\/strong\u003E:\u0026nbsp; \u0026nbsp;\u003Cstrong\u003ERana Hajjeh, MD\u003C\/strong\u003E\u003C\/p\u003E\u003Cp\u003EDivision Director, Bacterial Diseases, CDC\/OD\/NCIRD\u003Cbr \/\u003E Clinical Professor, Emory School of Medicine\u003Cbr \/\u003E Visting Professor, Bloomberg School of Public Health (Johns Hopkins)\u003C\/p\u003E\u003Cp\u003E\u0026nbsp;\u003Cstrong\u003EWhen\u003C\/strong\u003E: Friday, April 13\u003Csup\u003Eth\u003C\/sup\u003E from 3:00 \u2013 4:00 PM\u003C\/p\u003E\u003Cp\u003E\u0026nbsp;\u003Cstrong\u003EWhere\u003C\/strong\u003E:\u0026nbsp;Whitaker Lecture Hall 1103\u003C\/p\u003E\u003Cp\u003E\u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003C\/p\u003E\u003Cp\u003E\u003Cem\u003ESpeaker Bio:\u0026nbsp;\u003C\/em\u003E\u003C\/p\u003E\u003Cp\u003ERana Hajjeh did her undergraduate and medical studies at AUB (B.S. \u201984, M.D. \u201988).\u003Cbr \/\u003E During 1988-1993, she trained in Internal Medicine and Infectious Diseases at Emory\u003Cbr \/\u003E University, Atlanta, GA, and is board certified in both. In 1993, she joined the Epidemic\u003Cbr \/\u003E Intelligence Service (EIS) at the U.S. CDC for 2 years. She was the chief of the\u003Cbr \/\u003E epidemiology section, Mycotic Diseases in 1996 - 2003. During 2003-2005, Dr Hajjeh\u003Cbr \/\u003E was the director of the Surveillance Program at the U.S. Navy Medical Research Unit-3\u003Cbr \/\u003E (NAMRU3) in Cairo, Egypt, where she worked closely with WHO (EMRO), and various\u003Cbr \/\u003E countries in the region. During 2005-2009, Dr Hajjeh was the director of the Hib\u003Cbr \/\u003E Initiative, a project supported by the GAVI Alliance, as a collaboration between CDC,\u003Cbr \/\u003E Johns Hopkins School of Public Health, London School of Hygiene and Tropical\u003Cbr \/\u003E Medicine and WHO, which aimed at accelerating introduction of Hib vaccines in\u003Cbr \/\u003E developing countries. Currently, Dr Hajjeh is the director of the Division of Bacterial\u003Cbr \/\u003E Diseases at the Center of Immunizations and Respiratory Diseases, CDC, where she leads\u003Cbr \/\u003E a group of 180 staff. Dr. Hajjeh is fluent in Arabic, French and English. She has\u003Cbr \/\u003E published over 100 peer-reviewed papers, and many book chapters, and serves on the\u003Cbr \/\u003E editorial reviews of many journals.\u003C\/p\u003E\u003Cp\u003E\u0026nbsp;\u003C\/p\u003E\u003Cp\u003ECheers!\u003C\/p\u003E\u003Cp\u003E\u2013The BBUGS Public Policy\u003C\/p\u003E\u003Cp\u003EInthu Somasuntharam, Roy Wang and Alex Caulk\u003C\/p\u003E\u003Cp\u003E\u0026nbsp;\u003C\/p\u003E","summary":null,"format":"limited_html"}],"field_subtitle":"","field_summary":[{"value":"\u003Cp\u003EBBUGS Public Policy Seminar\u003C\/p\u003E\u003Cp\u003E\u003Cstrong\u003ELife in the Fast Lane:\u003Cbr \/\u003E What it Takes to Facilitate Accelerated Vaccine Introduction in Developing Countries when Scientists are from Venus and Policy Makers are from Mars \u2026\u003Cbr \/\u003E Lessons from the Hib Initiative\u003C\/strong\u003E\u003C\/p\u003E","format":"limited_html"}],"field_summary_sentence":[{"value":"Life in the Fast Lane: What it Takes to Facilitate Accelerated Vaccine Introduction in Developing Countries when Scientists are from Venus and Policy Makers are from Mars \u2026 Lessons from the Hib Initiative"}],"uid":"27565","created_gmt":"2012-04-10 15:12:14","changed_gmt":"2016-10-08 01:58:41","author":"Inthirai Somasuntharam","boilerplate_text":"","field_publication":"","field_article_url":"","field_event_time":{"event_time_start":"2012-04-13T20:00:00-04:00","event_time_end":"2012-04-13T21:00:00-04:00","event_time_end_last":"2012-04-13T21:00:00-04:00","gmt_time_start":"2012-04-14 00:00:00","gmt_time_end":"2012-04-14 01:00:00","gmt_time_end_last":"2012-04-14 01:00:00","rrule":null,"timezone":"America\/New_York"},"extras":["free_food"],"related_links":[{"url":"http:\/\/bbugs.gatech.edu\/)","title":"BBUGS"}],"groups":[{"id":"69452","name":"BBUGS"}],"categories":[],"keywords":[{"id":"29941","name":"BBUGS Public Policy"}],"core_research_areas":[],"news_room_topics":[],"event_categories":[{"id":"1795","name":"Seminar\/Lecture\/Colloquium"}],"invited_audience":[],"affiliations":[],"classification":[],"areas_of_expertise":[],"news_and_recent_appearances":[],"phone":[],"contact":[{"value":"\u003Cp\u003EInthu Somasuntharam (\u003Ca href=\u0022mailto:inthirai3@gatech.edu\u0022\u003Einthirai3@gatech.edu\u003C\/a\u003E)\u003C\/p\u003E\u003Cp\u003EBBUGS Public policy committee\u003C\/p\u003E","format":"limited_html"}],"email":[],"slides":[],"orientation":[],"userdata":""}}}